Phage Pharmaceuticals

Phage Pharmaceuticals, a specialty biopharmaceutical company, develops therapeutic products for niche markets and indications

For More Detailed Information About Phage Pharmaceuticals Please click the link below to view our

Business Overview

home_pic

News

Dec 20, 2011 / Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
Nov 08, 2011 / Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent
Oct 28, 2011 / Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech

Pipeline

Phage Pharmaceuticals has two product candidates in clinical development, FGF-1 and HGH, each of which has an open, active IND at the FDA. Phage’s product portfolio includes several additional recombinant therapeutic proteins in various stages of development.